Compare HQ & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HQ | INMD |
|---|---|---|
| Founded | 2018 | 2008 |
| Country | Singapore | Israel |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 879.7M | 805.0M |
| IPO Year | 2025 | 2018 |
| Metric | HQ | INMD |
|---|---|---|
| Price | $16.08 | $14.30 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 5 |
| Target Price | ★ $20.50 | $16.17 |
| AVG Volume (30 Days) | ★ 440.5K | 413.7K |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.30 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.29 | $12.72 |
| 52 Week High | $45.00 | $16.67 |
| Indicator | HQ | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 51.95 | 46.78 |
| Support Level | $13.68 | $14.19 |
| Resistance Level | $16.37 | $14.51 |
| Average True Range (ATR) | 1.22 | 0.16 |
| MACD | 0.18 | 0.03 |
| Stochastic Oscillator | 57.54 | 77.34 |
Horizon Quantum Holdings Ltd is building software infrastructure to make quantum computers accessible to commercial enterprises and hardware providers. By bridging the gap between hardware and applications, the company seeks to equip developers, researchers, and enterprises with the quantum software infrastructure needed to solve real-world problems. The company is developing tools that can automatically accelerate code written for conventional computers on quantum computers.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.